ArticleHealth science reports2025

The Clinical Value of Inflammatory Indicators at the Time of Secondary Infection After Treatment With Tocilizumab: A Cross-Sectional Study.

Dena Firouzabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.